This page last updated June 23, 2020
Under the guidelines issued by the NYS Governor, the NYC region entered Phase 2 of reopening on June 22, 2020. The Phase 2 reopening guidelines include certain on campus research activity and higher education administrative functions. In preparation for resuming certain on campus activities, in compliance with applicable federal, state and local laws, the University has developed this Plan for Gradual Return to Campus – Summer 2020 (the “Plan for Gradual Return to Campus”).
Based upon applicable guidance, St. John’s will implement a tentative schedule to gradually reopen its campuses for certain activities and functions. Employee, student and visitor safety are first and foremost as we implement these reopening plans. Accordingly, as discussed below, prior to returning to campus, all employees must sign and acknowledge this Plan for Gradual Return to Campus. The University must have the full cooperation of all employees to help protect students, employees and visitors, and slow the spread of COVID-19.
Under a best-case scenario, the NYC region will reopen under the following schedule:
During Phase 2, capacity is capped at 50% building occupancy with appropriate social distancing, health and safety requirements.
In order to limit density on campus and enhance social distancing, St. John’s has set the following caps for employees working on campus as part of a phased approach to gradual reopening:
All employees are expected to be working full-time. Thus, these caps represent the maximum number of employees working on campus during each phase of gradual reopening. All employees should check with their supervisor before attempting to gain access to campus.
The return of principal investigators, post-doctoral fellows, graduate students and associated research personnel to campus to continue research must be implemented in phases beginning at a small scale with restricted numbers of individuals and restricted access. A Plan for Gradual Resumption of Laboratory Research and Clinical Site Activities is provided in Attachment No. 4: Plan for Gradual Resumption of Laboratory Research and Clinical Site Activities.